Menu

Cardiff Oncology, Inc. CRDF

Full chart Compare
Set alert

Price alert · CRDF

All alert types
0.79 USD 0.00 (+0.00%)

At closeNov 10, 2026, 4:00 PM EST

0.80 0.00 +0.42%

After hours · Nov 10, 4:00 PM ET

Day range unavailable

0.75 52-week range 3.31
YTD
-71.72%
1 year
-64.36%

Revenue & Expenses

Other Income → Expenses: $3.11MExpenses → Selling, General & Admin: $14.22MExpenses → Research & Development: $35.33MGross Profit → Expenses: $593.00KRevenue → Gross Profit: $593.00KNet Loss → Expenses: $45.85MOther Income$3.11MGross Profit$593.00KNet Loss$45.85MExpenses$49.55MSelling, General & Admin$14.22MResearch & Development$35.33MRevenue$593.00K

Latest period ending Dec 31, 2025 · select a line to chart its full history

CRDF annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
593.00K683.00K488.00K386.00K359.00K
593.00K683.00K488.00K386.00K359.00K
-48.96M-48.65M-45.41M-39.90M-28.86M
-45.85M-45.43M-41.44M-38.70M-28.29M
-0.69-0.95-0.93-0.89-0.73
CRDF annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
17.47M51.47M21.66M16.35M11.94M
61.88M97.19M81.64M116.19M149.54M
16.50M14.24M11.90M9.85M9.13M
832.00K1.52M2.15M2.71M3.12M
45.39M82.95M69.74M106.34M140.42M
CRDF annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-37.92M-37.69M-30.89M-33.82M-23.04M
1.34M13.73M36.20M38.15M-131.45M
2.58M53.78M075.00K35.45M
-44.00K-80.00K-582.00K-1.01M-205.00K
-34.00M29.82M5.31M4.40M-119.04M